A polymorphism in the TNF-α promoter resulting in enhanced plasma TNF-α has been associated with an increased incidence of prostate cancer [139], while a polymorphism increasing IL-1β production conferred a greater susceptibility to gastric cancer [140,141]. Here, TNF is linked to prostate carcinoma.